Clinical Trial Update: NK Cell Therapy Recurrent/Refractory Elderly AML [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for NK cell therapy in recurrent/refractory elderly AML spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• NK cell therapy

Snippet

Sponsor: The Second Hospital of Shandong University | Conditions: AML, Recurrent | Phase 1, Phase 2 | Status: UNKNOWN